跳至主要内容
临床试验/NCT03923309
NCT03923309已完成不适用

Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer: a Multicenter Comparative Study With Rectal Preservation as Supported by Surgeon

Seoul National University Hospital3 个研究点 分布在 1 个国家目标入组 142 人开始时间: 2016年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
142
试验地点
3
主要终点
3-year overall survival

研究概览

简要总结

Though refusal of radical surgery was often happened in rectal cancer patient after neoadjuvant chemoradiotherapy, little is currently known about the actual oncologic outcome of it. Thus the investigators designed this study to compare the oncologic outcome of unintended rectal preservation with intended rectal preservation by surgeon.

详细描述

The investigators identified patients whose organ were preserved by non-operative management or local excision after neoadjuvant chemoradiotherapy for mid to low rectal cancer. Then, the patients were categorized into two groups according to the agreement on omitting radical surgery (rectal preservation). When treatment decision was agreed by their surgeon, the patients were categorized as intended rectal preservation. When there was disagreement by surgeon on rectal preservation, then the patients categorized as unintended rectal preservation. Oncologic outcome was compared between two groups.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • biopsy proven rectal cancer (anal verge ≤ 10cm)
  • neoadjuvant radiotherapy or chemoradiotherapy
  • no radical surgery after neoadjuvant therapy

排除标准

  • other malignant disease
  • other fatel disease
  • incompletion of half of radiotherapy course
  • metastasis on initial presentation

结局指标

主要结局

3-year overall survival

时间窗: from date of completion of chemoradiotherapy until the date of death from any cause, whichever came first, assessed at 31th December 2017 by checking expire date of a resident registration number

Overall survival rate at 3-year after completion of chemoradiotherapy

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sung-Bum Kang

Colorectal Surgeon, University Professor

Seoul National University Hospital

研究点 (3)

Loading locations...

相似试验